Gonadorelin Intravenous, Injection and Ifex/Mesnex Kit

• Generic Name: gonadorelin
• Dosage Forms: n.a.
• Other Brand Names:

Gonadorelin is a medicine that is the same as gonadotropin-releasing hormone (GnRH) that is naturally released from the hypothalamus gland. GnRH causes the pituitary gland to release other hormones (luteinizing hormone [LH] and follicle-stimulating hormone [FSH]). LH and FSH control development in children and fertility in adults.

Gonadorelin is used to test how well the hypothalamus and the pituitary glands are working. It is also used to cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods because the hypothalamus gland does not release enough GnRH.

Gonadorelin may also be used for other conditions as determined by your doctor.

• Generic Name: ifosfamide
• Dosage Forms: n.a.
• Other Brand Names: Ifex

Component of various chemotherapeutic regimens as third-line therapy for recurrent or refractory germ cell testicular cancer (designated an orphan drug by FDA for this use).

Component of various chemotherapeutic regimens in conjunction with surgery and/or radiation therapy in the treatment of various soft tissue sarcomas (designated an orphan drug by FDA for this use).

Used alone or in conjunction with other drugs (e.g., etoposide) for treatment of localized, metastatic, and recurrent osteosarcoma (designated an orphan drug by FDA for this use).

Used alone or in combination with other antineoplastic agents for treatment of advanced or metastatic bladder cancer.

Treatment of small cell lung cancer as part of a combination regimen.

Component of various combination regimens (e.g., cisplatin and ifosfamide with or without bleomycin) for the treatment of metastatic or recurrent cervical cancer.

Used alone or in conjunction with other antineoplastic agents for second-line (salvage) therapy in patients with advanced or recurrent ovarian carcinoma.

Treatment of advanced small noncleaved cell lymphoma (Burkitt’s and non-Burkitt’s) in children as part of a combination regimen.